middl
east
respiratori
syndromeassoci
coronaviru
merscov
signific
research
focu
sinc
discoveri
sinc
case
death
record
august
repres
strikingli
high
case
fatal
rate
last
sever
year
merscov
research
progress
sever
parallel
complementari
direct
review
focu
three
particular
area
origin
evolut
merscov
challeng
achiev
develop
merscov
anim
model
understand
novel
protein
uniqu
merscov
counter
host
immun
respons
origin
merscov
like
african
bat
increasingli
clear
although
import
question
remain
establish
dromedari
camel
reservoir
seed
human
outbreak
likewis
import
advanc
develop
anim
model
nonhuman
primat
mous
model
seem
recapitul
human
diseas
avail
merscov
evad
inhibit
host
innat
immun
respons
remain
less
clear
although
sever
studi
identifi
merscov
protein
innat
immun
antagonist
littl
work
conduct
use
live
viru
condit
actual
infect
rather
ectop
express
protein
accordingli
consider
space
remain
major
contribut
understand
uniqu
way
merscov
interact
modul
host
respons
collect
area
seen
signific
advanc
last
sever
year
continu
offer
excit
opportun
discoveri
middl
east
respiratori
syndrom
associatedcoronaviru
merscov
first
isol
patient
sever
fatal
pneumonia
saudi
arabia
septemb
retrospect
identifi
jordan
april
date
vast
major
confirm
case
death
august
occur
kingdom
saudi
arabia
world
health
organ
one
larg
travelassoci
outbreak
occur
south
korea
merscov
larg
kb
positivesens
rna
genom
characterist
coronavirus
encod
conserv
replicas
structur
gene
lineagespecif
accessori
gene
found
kb
genom
merscov
research
branch
sever
parallel
direct
given
unusu
high
case
fatal
rate
paramount
concern
understand
ecolog
emerg
merscov
order
assess
pandem
potenti
equal
import
interest
develop
vaccin
therapeut
understand
merscov
actual
caus
diseas
driven
extens
work
develop
larg
small
anim
model
well
studi
molecular
virushost
interact
contribut
viral
replic
virul
review
examin
sever
area
assess
state
field
specif
focu
four
area
emerg
clariti
zoonot
origin
evolut
merscov
bat
camel
develop
nonhuman
primat
model
gener
transgen
mous
model
studi
pathogenesi
test
vaccin
therapeut
studi
attempt
elucid
mechan
merscov
evad
counteract
host
innat
immun
respons
though
exhaust
discuss
area
provid
clear
pictur
state
knowledg
field
import
gap
remain
outstand
question
remain
particularli
consid
sourc
merscov
infect
human
although
larg
percentag
case
report
contact
camel
mani
largescal
serosurvey
suggest
rare
widespread
subclin
infect
unknown
whether
asymptomat
infect
individu
transmit
viru
notabl
seroposit
rate
among
dromedari
camel
exceed
detect
sever
subsaharan
african
countri
addit
middl
east
singl
activ
merscov
infect
identifi
subsaharan
africa
sampl
individu
kenya
identifi
two
seroposit
individu
although
individu
test
includ
two
test
posit
littl
contact
camel
unclear
whether
absenc
case
report
africa
due
underreport
differ
ecolog
viru
intensifi
sampl
may
fill
gap
sinc
discoveri
merscov
identifi
sourc
human
infect
consid
essenti
interrupt
zoonot
transmiss
almost
immedi
suspicion
fell
bat
like
reservoir
merscov
classifi
genom
lineag
c
betacoronaviru
rel
novel
lineag
typifi
bat
coronavirus
complet
sequenc
recov
bat
speci
tylonycteri
pachypu
pipistrellu
abramu
china
respect
extens
global
survey
sinc
discoveri
merscov
reveal
remark
wide
distribut
lineag
c
betacoronavirus
bat
lineag
c
betacoronavirus
sinc
identifi
bat
itali
mexico
thailand
recent
global
studi
anthoni
et
al
found
phylogenet
coronaviru
lineag
identifi
divers
mammalian
order
found
bat
suggest
bat
sourc
lineag
c
betacoronavirus
possibl
vast
major
global
coronaviru
divers
memish
et
al
survey
bat
vicin
small
human
outbreak
saudi
arabia
report
identif
nt
fragment
ident
merscov
polymeras
singl
bat
provid
limit
evid
merscov
close
relat
viru
circul
arabian
peninsula
howev
viru
could
isol
local
region
bat
later
work
appear
close
origin
subsaharan
africa
merscov
also
ithet
et
al
describ
short
fragment
coronaviru
rna
isol
neoromicia
zuluensi
bat
south
africa
differ
one
amino
acid
equival
merscov
fragment
much
closer
relationship
merscov
previous
describ
viru
analysi
complet
genom
sequenc
viru
neocov
corman
et
al
reveal
share
nt
ident
merscov
across
entir
genom
amino
acid
ident
place
two
virus
within
speci
recent
second
viru
speci
describ
anthoni
et
al
support
idea
merscov
descend
ancestr
viru
african
bat
despit
close
similar
conspecif
classif
neocov
merscov
two
bat
virus
highli
diverg
merscov
subunit
spike
glycoprotein
less
nt
amino
acid
ident
highli
similar
evid
recombin
subunit
unabl
infect
human
cell
consist
idea
merscov
common
ancestor
virus
aros
acquisit
new
spike
subunit
confer
abil
infect
human
cell
receptor
although
bat
origin
seem
like
epidemiolog
link
human
merscov
infect
bat
epidemiolog
genet
phenotyp
link
dromedari
camel
human
infect
seem
conclus
serolog
evid
merscov
infect
dromedari
camel
date
back
least
et
al
report
seroposit
merscov
bank
dromedari
serum
sampl
obtain
somalia
sudan
egypt
first
two
countri
major
export
dromedari
camel
arabian
peninsula
support
extens
circul
merscov
dromedari
camel
long
predat
known
human
case
corman
et
al
report
similarli
high
seroposit
rate
kenyan
camel
serum
bank
contemporari
serum
collect
show
high
percentag
dromedari
camel
also
seroposit
merscov
nigeria
tunisia
ethiopia
well
burkina
faso
morocco
phylogenet
analysi
merscov
sequenc
suggest
evolutionari
histori
merscov
camel
sabir
et
al
isol
complet
merscov
sequenc
repres
five
genet
lineag
saudi
arabian
camel
lineag
includ
one
recombin
lineag
spawn
human
outbreak
appear
ancestr
human
isol
despit
intens
research
last
five
year
remark
littl
known
merscov
pathogenesi
owe
religi
restrict
autopsi
merscov
endem
region
one
postmortem
report
publish
autopsi
report
emerg
outbreak
elsewher
absenc
robust
postmortem
data
human
numer
attempt
made
establish
nonhuman
primat
model
recapitul
sever
human
diseas
caus
merscov
although
attempt
partial
success
work
point
illumin
cellular
tropism
merscov
vivo
shed
light
type
damag
inflammatori
respons
caus
elicit
airway
lone
autopsi
report
stem
april
case
unit
arab
emir
identifi
type
alveolar
pneumocyt
respiratori
multinucl
syncyti
cell
uncertain
origin
primari
target
merscov
consist
tropism
cell
lower
airway
primari
patholog
observ
diffus
alveolar
damag
evid
immunemedi
patholog
uninfect
area
lung
evid
system
dissemin
merscov
found
data
singl
patient
rule
possibl
spread
beyond
airway
anim
model
inconsist
question
whether
merscov
caus
system
infect
renal
failur
known
complic
sever
human
case
earliest
merscov
anim
model
establish
use
rhesu
macaqu
de
wit
et
al
yao
et
al
respect
report
rhesu
macaqu
infect
merscov
experi
selflimit
transient
lower
respiratori
tract
infect
involv
mild
moder
pneumonia
therefor
mimick
sever
human
diseas
associ
merscov
howev
studi
match
observ
lone
autopsi
report
merscov
target
primarili
alveolar
pneumocyt
conflict
whether
lung
endotheli
cell
infect
observ
cell
cultur
could
facilit
system
dissemin
allow
viral
escap
lung
effort
sever
group
develop
nonhuman
primat
model
sever
merscovinduc
diseas
use
common
marmoset
falzarano
et
al
first
report
infect
marmoset
merscov
caus
sever
pneumonia
lethal
subject
appear
recapitul
human
diseas
group
yu
et
al
subsequ
compar
merscov
infect
marmoset
rhesu
macaqu
observ
sever
diseas
robust
viral
replic
sever
patholog
inflammatori
cell
lung
infiltr
marmoset
rhesu
macaqu
report
indic
marmoset
serv
suitabl
model
sever
human
diseas
caus
merscov
support
role
immunemedi
patholog
lung
factor
sever
diseas
howev
confound
result
johnson
et
al
report
intratrach
infect
marmoset
merscov
result
mild
pneumonia
minim
viral
replic
lung
found
signific
differ
diseas
merscovinfect
marmoset
marmoset
inocul
inactiv
merscov
suggest
volum
intratrach
viral
inoculum
might
result
airway
patholog
resolv
differ
studi
requir
consider
work
interim
common
marmoset
appear
use
model
organ
studi
pathogenesi
sever
merscov
diseas
rhesu
macaqu
may
appropri
studi
milder
like
underreport
human
diseas
well
vaccin
studi
merscov
replic
mice
mous
support
merscov
entri
due
two
amino
acid
differ
rel
human
region
interact
spike
therefor
develop
mous
model
larg
involv
replac
mous
human
modif
render
compat
spike
first
mous
model
establish
gener
transgen
mice
use
adenovirusmedi
transient
express
mous
airway
via
adenovirusvector
transduct
zhao
et
al
report
transient
express
render
mice
suscept
merscov
replic
lung
develop
sign
symptom
pneumonia
howev
mice
recov
clear
viru
day
postinfect
fail
recapitul
sever
human
diseas
subsequ
sever
model
use
transgen
human
mice
develop
yet
suffer
signific
limit
abil
recapitul
human
diseas
first
transgen
mous
model
describ
agraw
et
al
character
use
mice
global
express
mice
develop
pneumonia
seen
human
viru
dissemin
system
includ
robust
viral
replic
brain
also
zhao
et
al
describ
similar
transgen
mous
model
like
limit
util
pathogenesi
studi
due
system
dissemin
sever
neurolog
diseas
suitabl
studi
efficaci
vaccin
antivir
drug
similar
result
report
li
et
al
although
group
also
use
express
control
lungspecif
promot
observ
diseas
follow
merscov
infect
recent
three
model
use
transgen
mice
appear
better
recapitul
sever
human
diseas
publish
first
describ
pascal
et
al
detail
coleman
et
al
use
mice
fulllength
mous
gene
replac
human
equival
tissu
distribut
express
level
system
larg
equival
wildtyp
mice
mice
support
robust
merscov
replic
lung
littl
dissemin
viru
organ
mice
infect
highest
dose
plaqueform
unit
pfu
develop
sever
lung
patholog
lost
bodi
weight
day
postinfect
euthan
notabl
unlik
model
describ
mice
succumb
infect
wildtyp
rather
mouseadapt
merscov
may
make
particularli
use
extens
vitro
studi
mutat
found
clinic
isol
delet
mutat
engin
viral
protein
intend
disrupt
interact
host
immun
respons
two
mous
model
publish
late
earli
use
mice
modifi
use
serv
function
receptor
merscov
cockrel
et
al
made
two
amino
acid
substitut
previous
determin
enabl
usag
merscov
posit
mice
support
robust
replic
lung
follow
intranas
inocul
pfu
wildtyp
merscov
merscov
adapt
mous
cell
express
chimer
substitut
amino
acid
howev
mice
exhibit
clinic
sign
diseas
minim
lung
patholog
despit
robust
replic
serial
passag
viru
requir
achiev
lethal
signific
declin
respiratori
function
sever
lung
patholog
mouseadapt
viru
contain
sever
mutat
expect
well
larg
delet
delet
may
suggest
protein
nonessenti
mous
loss
may
repres
adapt
virul
possibl
loss
put
interferon
ifn
antagonist
result
enhanc
immunemedi
patholog
li
et
al
develop
similar
model
replac
exon
mous
human
equival
render
function
receptor
merscov
model
develop
cockrel
et
al
wildtyp
merscov
replic
robustli
lung
mice
caus
diseas
viru
serial
passag
time
lethal
mice
infect
pfu
notabl
support
emerg
pictur
immunemedi
patholog
play
signific
role
diseas
mouseadapt
merscov
use
model
induc
significantli
robust
activ
innat
immun
inflammatori
gene
wildtyp
merscov
increas
infiltr
airway
innat
immun
cell
like
mani
virus
coronavirus
encod
protein
enabl
evas
suppress
host
innat
immun
respons
particularli
driven
express
antivir
type
type
iii
ifn
notabl
howev
ifn
respons
coronaviru
infect
occur
remark
late
compar
mani
virus
merscov
induc
littl
detect
ifn
ifnstimul
gene
isg
express
earli
infect
primari
airway
epitheli
cell
ex
vivo
lung
cultur
immort
airwayderiv
epitheli
cell
hepatoma
cell
type
ifn
transcript
could
detect
even
hour
postinfect
hpi
although
menacheri
et
al
shown
airwayderiv
cell
mount
ifn
respons
hpi
high
concentr
merscov
accordingli
consider
research
conduct
identifi
viral
protein
dramat
delay
host
immun
respons
particular
interest
lineagespecif
accessori
protein
encod
end
merscov
genom
conserv
merscov
protein
papainlik
proteas
domain
structur
protein
may
also
counteract
host
immun
respons
like
similar
mechan
close
relat
ortholog
coronavirus
lineagespecif
accessori
protein
contrast
lack
homolog
known
viral
host
protein
make
particular
interest
mechan
action
may
uniqu
among
coronavirus
notabl
demonstr
multipl
group
ifn
antagon
capabl
may
well
howev
studi
investig
role
protein
infect
instead
studi
use
ectop
express
viral
protein
experiment
approach
offer
advantag
avoid
need
high
contain
isol
protein
activ
viral
protein
accessori
protein
translat
bicistron
also
identifi
innat
immun
antagonist
rapidli
identifi
doublestrand
rna
dsrna
bind
protein
though
uniqu
merscov
merslik
coronavirus
rna
bind
domain
homolog
sever
cellular
protein
antagon
ifn
gene
express
demonstr
three
research
group
use
similar
luciferas
report
assay
like
actual
viru
infect
notabl
niemey
et
al
show
bind
dsrna
mimic
polyi
c
coloc
dsrna
merscov
infect
wherea
siu
et
al
demonstr
ifn
antagon
depend
dsrna
bind
recent
rabouw
et
al
report
ectop
express
inhibit
activ
antivir
dsrna
bind
protein
pkr
prevent
translat
arrest
stress
granul
format
howev
infect
recombin
induc
stress
granul
format
whether
viru
activ
pkr
report
leav
open
question
whether
function
pkr
antagonist
merscov
infect
initi
identifi
put
ifn
antagonist
yang
et
al
matthew
et
al
use
luciferas
report
assay
gene
express
yang
et
al
show
nuclear
transloc
notabl
matthew
et
al
found
although
local
primarili
nucleu
delet
ntermin
nuclear
local
sequenc
abrog
inhibit
promoterdriven
luciferas
express
result
confirm
yang
et
al
studi
yang
et
al
expand
earlier
work
show
ectop
express
inhibit
promoterdriven
luciferas
express
consequ
overexpress
ifn
activ
rigi
mav
rigi
cellular
sensor
viral
dsrna
wherea
mav
transduc
recognit
dsrna
kinas
phosphoryl
induc
ifn
demonstr
associ
sever
antivir
protein
prevent
format
complex
requir
induc
ifn
yet
author
identifi
character
ifn
antagonist
function
mediat
specif
nucleu
final
identifi
phosphodiesteras
pde
structur
homolog
mous
hepat
viru
mhv
protein
well
larger
host
protein
famili
known
previous
character
mhv
rnase
l
antagonist
show
function
replac
mhv
addit
use
recombin
live
merscov
demonstr
mutat
catalyt
residu
abrog
enzymat
activ
result
rnase
l
activ
cell
late
infect
collect
great
deal
progress
made
area
last
sever
year
also
clear
field
merscov
research
still
infanc
respect
origin
merscov
increasingli
understood
yet
remain
true
viru
directli
ancestr
merscov
contain
spike
subunit
high
similar
merscov
either
isol
identifi
sequenc
addit
host
switch
bat
dromedari
camel
like
occur
africa
bank
saudi
arabian
camel
serum
date
seroposit
merscov
suggest
viru
also
circul
year
ago
africa
recent
experiment
work
camel
support
statu
merscov
reservoir
hallmark
featur
virusreservoir
host
interact
viru
maintain
reservoir
host
popul
caus
minim
diseas
host
experiment
infect
jamaican
fruit
bat
munster
et
al
result
replic
shed
without
clinic
diseas
although
abil
extrapol
conclus
limit
bat
put
merscov
reservoir
notabl
support
identif
dromedari
camel
reservoir
seed
human
infect
merscov
infect
camel
natur
experiment
set
result
either
subclin
caus
mild
transient
upper
respiratori
tract
diseas
work
better
understand
ecolog
merscov
includ
continu
intens
serosurvey
effort
isol
bat
coronavirus
acquisit
analysi
addit
camelderiv
merscov
sequenc
date
geoloc
merscov
evolut
hostswitch
work
understand
process
underli
zoonot
emerg
novel
virus
evergrow
threat
chang
climat
respect
anim
model
use
nonhuman
primat
mous
model
develop
yet
work
remain
reconcil
differ
rhesu
macaqu
may
readili
avail
marmoset
yet
develop
mild
diseas
may
less
use
studi
pathogenesi
therapeut
addit
strikingli
conflict
result
marmoset
merscov
infect
depend
research
group
requir
reconcili
model
wide
adopt
develop
merscov
mous
model
impress
scientif
achiev
differ
infect
outcom
mice
express
locu
mice
express
chimer
requir
studi
notabl
latter
two
model
requir
mous
adapt
viru
still
requir
viru
achiev
sever
diseas
possibl
full
replac
disrupt
nonmerscovrel
function
includ
tcell
homeostasi
could
affect
cours
diseas
use
differ
merscov
strain
may
also
affect
outcom
sidebysid
comparison
model
help
elucid
reconcil
differ
respect
pathogenesi
three
model
appear
recapitul
pneumonia
observ
human
model
use
wildtyp
viru
may
offer
certain
advantag
particularli
better
allow
studi
natur
occur
engin
mutat
viral
protein
genet
background
human
isol
particularli
accessori
protein
end
genom
sever
protein
identifi
vitro
put
innat
immun
antagonist
potenti
extend
studi
character
role
protein
pathogenesi
offer
excit
opportun
field
area
uniqu
mechan
merscov
use
evad
counteract
host
immun
respons
remain
ripe
studi
none
merscov
accessori
protein
share
signific
amino
acid
ident
similar
known
coronaviru
protein
suggest
interact
host
may
uniqu
lineag
c
betacoronavirus
contrast
replicas
structur
gene
interfer
immun
respons
remain
interest
owe
conserv
among
coronavirus
less
like
act
uniqu
newli
recogn
way
although
report
interfer
innat
immun
respons
work
includ
relat
ifn
induct
done
use
ectop
express
protein
report
assay
exclus
use
ectop
express
protein
rais
concern
whether
result
may
skew
nonphysiolog
express
level
misloc
loss
possibl
interact
viral
protein
although
studi
use
live
viru
cumbersom
requir
biosafeti
contain
essenti
feasibl
given
exist
multipl
system
gener
recombin
merscov
author
declar
compet
interest
srw
receiv
fund
nation
institut
allergi
infecti
diseas
nation
institut
health
award
number
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
